Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva Heads to Biggest Drop Since 2006 on New Competition: Israel Overnight
Bloomberg
Friday, December 30, 2011 - 9:13am
tags:
Teva Pharmaceuticals, morning-after pill, Copaxone
Amgen: Xgeva panel review scheduled for February
Yahoo/AP
Thursday, December 29, 2011 - 10:35pm
tags:
Amgen, Xgeva, advisory panel, FDA, prostate cancer
What to Look For With Seattle Genetics in 2012
Motley Fool
Thursday, December 29, 2011 - 10:34pm
tags:
Seattle Genetics, Adcetris
What to Look For From Keryx and Aeterna Zentaris in 2012
Motley Fool
Thursday, December 29, 2011 - 10:32pm
tags:
Keryx, Aeterna Zentaris, colon cancer, perifosine
Peregrine Provides Update on HCV Clinical Program
Yahoo
Thursday, December 29, 2011 - 10:30pm
tags:
HCV, Peregrine Pharmaceuticals, bavituximab
Is 2012 Make or Break for Cell Therapeutics?
Motley Fool
Thursday, December 29, 2011 - 10:28pm
tags:
Cell Therapeutics, pixantrone
Why Profitable Pfizer Won't Fall Off The Patent Cliff Anytime Soon
Seeking Alpha
Thursday, December 29, 2011 - 10:17pm
tags:
Pfizer, patents, patent cliff
Biotech Stocks At A Critical Juncture
Investopedia.com
Thursday, December 29, 2011 - 1:32pm
tags:
Jazz Pharmaceuticals, Oncothyreon, Questcor, Indenix
Pfizer's offer of discount Lipitor prompts outcry
Winston-Salem Journal, NC
Thursday, December 29, 2011 - 12:43pm
tags:
Lipitor, Pfizer, drug discounts
Five Predictions For Biotech And Medicine In 2012
Forbes
Thursday, December 29, 2011 - 12:35pm
tags:
biotech, India, devices, genetics, PBMs
Ring in Generics in 2012 and Beyond
Zacks.com
Thursday, December 29, 2011 - 12:13pm
tags:
generics, Dr Reddy's, Sanofi, Forest Labs, Watson, Pfizer, Eli Lilly, Novartis, JNJ, Teva Pharmaceuticals, Abbott Laboratories, Mylan, Merck
Onyx put selling hinges on time decay
Yahoo/optionMONSTER
Thursday, December 29, 2011 - 12:01pm
tags:
ONYX Pharmaceuticals, regorafenib
Abbott Labs: Dividend Dynamo or the Next Blowup?
Motley Fool
Thursday, December 29, 2011 - 11:53am
tags:
Abbott Laboratories, dividends
Teva Pharmaceutical Releases Generic Version of HIV Drug in U.S.
Bloomberg
Thursday, December 29, 2011 - 11:53am
tags:
Teva Pharmaceuticals, generics, HIV, GSK, Combivir
Johnson & Johnson seeks FDA approval for third use for its new anticlotting drug, Xarelto
Yahoo/AP
Thursday, December 29, 2011 - 11:52am
tags:
JNJ, FDA, anti-clotting, Xarelto
5-Star Stocks Poised to Pop: Novartis
Motley Fool
Thursday, December 29, 2011 - 11:51am
tags:
Novartis
Illumina Accuses Life Technologies of Infringing Patent
Bloomberg
Thursday, December 29, 2011 - 10:06am
tags:
Illumina, Life Technologies, patents
Marshall Edwards Adds $2 Million in Private Placement
Yahoo
Thursday, December 29, 2011 - 10:05am
tags:
Marshall Edwards, financing
2 Healthcare Stocks That Should Rebound In 2012 After A Poor 2011
Seeking Alpha
Thursday, December 29, 2011 - 10:04am
tags:
Warner Chilcott, Life Technologies
Mead Johnson confirms FDA visits in Enfamil probe
Reuters
Thursday, December 29, 2011 - 10:03am
tags:
FDA, Enfamil, Mead Johnson, infant formula

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.